Life expectancy for patients with thalassemia major (TM) has greatly improved, and their hopes are now directed towards attainment of better quality of life. The growth retardation of many of these patient becomes a major concern for the patients, their families, and the medical care-giver.
|Original language||American English|
|Title of host publication||Endocrine Disorders in Thalassemia|
|Editors||Prof. Dr. Sebastiano Andò, Prof. Dr. Carlo Brancati|
|State||Published - 1995|